Exercise Program for Restless Legs Syndrome
(PEARLS Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial does not specify whether you need to stop taking your current medications, but it requires that participants have untreated restless legs syndrome (RLS). This suggests that you should not be on any current treatment for RLS to participate.
What data supports the effectiveness of the 12-Week RLS Exercise Program treatment for Restless Legs Syndrome?
Research shows that regular exercise can improve symptoms of Restless Legs Syndrome (RLS), with 54% of survey participants reporting that exercise only improves their symptoms. Additionally, a study found that a pain-free walking exercise program reduced RLS symptoms in patients with peripheral artery disease, suggesting exercise can be beneficial for managing RLS.12345
Is the Exercise Program for Restless Legs Syndrome safe for humans?
How does the 12-Week RLS Exercise Program treatment differ from other treatments for Restless Legs Syndrome?
The 12-Week RLS Exercise Program is unique because it focuses on physical activity as a treatment, which is different from typical drug-based therapies. This program emphasizes exercise to improve physical function and potentially alleviate symptoms, similar to how exercise is used to manage frailty in older adults.1112131415
What is the purpose of this trial?
The goal of this clinical trial is to learn how exercise changes molecules in the blood in people with restless legs syndrome (RLS) to better understand the cause(s) of RLS. The main questions the investigators aim to answer are:How does long-term exercise change proteins in the blood?How does a single exercise session change proteins in the blood?The investigators will compare long-term exercise to no exercise to see if the changes in proteins are specific to exercise.Participants will complete an exercise test and provide blood samples before and after the exercise test. Participants will be randomized (like the flip of a coin) in to either the exercise or no-exercise group for 12 weeks and then complete the exercise test and blood samples again at the end.
Research Team
Emmanuel Mignot, MD
Principal Investigator
Stanford University
Eligibility Criteria
This trial is for adults over 18 with moderate-to-severe untreated Restless Legs Syndrome (RLS) who can walk without assistance. Participants should not be regularly active, defined as engaging in activity for more than two days a week in the past six months.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants complete an exercise test and provide blood samples before and after the exercise test
Intervention
Participants are randomized into either the exercise or no-exercise group for 12 weeks
Follow-up
Participants complete the exercise test and provide blood samples again at the end of the 12-week period
Treatment Details
Interventions
- 12-Week RLS Exercise Program
Find a Clinic Near You
Who Is Running the Clinical Trial?
Stanford University
Lead Sponsor